News and Media Release
18 October 2018
AfriAg Global
Plc
(“AfirAg” or the
“Company”)
First Medicinal
Cannabis Investment
London, October 18, 2018: AfriAg Global PLC
(“AfriAg”or the “Company”), the substantial London-quoted global food and logistics group,
focussed on the agricultural and medicinal cannabis sectors, has
today acquired 546 Tilray Inc (NASDAQ: TLRY) shares at US$146.439 per share for a total of US$80,000 or GBP61,000.
David Lenigas, Executive Chairman of
AfriAg Global, comments:
“This is AfriAg
Global’s first investment in the medical cannabis sector. We are
totally focused on investing in many more legal cannabis entities,
private or listed. We see Tilray as excellent value at this price
and are regarded as a long-term hold in our new cannabis investment
portfolio. This initial investmet may increase in time, and we are
looking hard at investments in other main board US listed public
entities in this sector. We are also actively reviewing many
opportunities around the globe in the legalised medical cannabis
space. Further releases will be made as when further investments
are made in this sector.”
The directors of the Company accept responsibility for the
contents of this announcement.
-ENDS-
For further information on AfriAg Global please visit the
www.afriagglobal.com or please contact;
AfriAg Global
Plc:
David Lenigas (Executive
Chairman)
+44 (0)20 7440 0640
Peterhouse Capital
Limited
+44 (0)20 7469 0930
Guy Miller
Fungai Ndoro
For Media enquiries:
David Bick at Square1
Consulting
+44 (0)20 7929 5599
About AfriAg Global Plc
AfriAg Global is a London
quoted public company (NEX Exchange), that specialises is global
agri-logistics solutions, food marketing and bespoke distribution
services by road, air and sea, to many major food retailers and
wholesale corporations around the world. AfriAg’s investment
strategy focuses on acquisitions of direct and/or indirect
interests in the agricultural and medicinal cannabis sectors. In
the Agriculture sector, AfriAg is seeking acquisitions of direct
and/or indirect interests in businesses involved in agriculture
generally and the production, processing, logistics and
distribution of agricultural produce. The Company is focusing on
opportunities in this sector in Europe, Africa and the Middle East, but is considering investment
opportunities anywhere in the world. In the Medicinal Cannabis
sector, the company is seeking investments in companies, projects
or products that are; progressing medicinal cannabis research and
development, producing or cultivating medicinal cannabis, producing
or supplying products derived from or related to cannabis
(including, but not limited to, hemp and cannabidiol products);
and/or commercialising or marketing medicinal cannabis and its
derivatives. The Company will seek investments in companies and
projects in jurisdictions which have well-developed and reputable
laws and regulations for the research and production of medicinal
cannabis and in jurisdictions that are signatories to the United
Nation’s conventions on narcotics.
